Iloprost Patent Expiration

Iloprost was first introduced by Actelion Pharmaceuticals Us Inc in its drug Ventavis on Dec 29, 2004. Another drug containing Iloprost is Aurlumyn. 2 different companies have introduced drugs containing Iloprost.


Iloprost Patents

Given below is the list of patents protecting Iloprost, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Aurlumyn US12409183 Jul 18, 2044 Btg Intl
Aurlumyn US12409184 Aug 06, 2041 Btg Intl



Iloprost's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Iloprost Generic API Manufacturers

Given below is the list of companies who have filed for Iloprost generic, along with the locations of their manufacturing plants worldwide.